137 related articles for article (PubMed ID: 2901936)
1. Fourth histamine antagonist, nizatidine, reaches U.S. market.
Clin Pharm; 1988 Aug; 7(8):560. PubMed ID: 2901936
[No Abstract] [Full Text] [Related]
2. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
Lima M; Holdcroft C
Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
[TBL] [Abstract][Full Text] [Related]
3. [Nizatidine].
Romero M; Franzosi MG
Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
[TBL] [Abstract][Full Text] [Related]
4. Nizatidine (AXID).
Med Lett Drugs Ther; 1988 Aug; 30(772):77-8. PubMed ID: 2899835
[No Abstract] [Full Text] [Related]
5. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C
Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
[TBL] [Abstract][Full Text] [Related]
6. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
7. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
Müller P; Dammann HG; Simon B
Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
[No Abstract] [Full Text] [Related]
8. Histamine H2-receptor antagonists.
Pounder R
Baillieres Clin Gastroenterol; 1988 Jul; 2(3):593-608. PubMed ID: 2901868
[TBL] [Abstract][Full Text] [Related]
9. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
Cerulli MA; Cloud ML; Offen WW; Chernish SM; Matsumoto C
Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of famotidine and ranitidine in duodenal ulcer].
Rohner HG; Gugler R; Kimmig JM; Schönekäs H
Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
[No Abstract] [Full Text] [Related]
11. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Price AH; Brogden RN
Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
[TBL] [Abstract][Full Text] [Related]
12. Nizatidine in peptic ulcer disease. Proceeedings of the First International Symposium on Nizatidine. Vienna, 11 and 12 October 1986.
Scand J Gastroenterol Suppl; 1987; 136():1-88. PubMed ID: 2892250
[No Abstract] [Full Text] [Related]
13. Famotidine (Pepcid).
Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
[No Abstract] [Full Text] [Related]
14. The new H2-antagonists--are we prescribing them?
Gilliland A; Mills K; Steele K
J R Coll Gen Pract; 1989 Sep; 39(326):387. PubMed ID: 2575170
[No Abstract] [Full Text] [Related]
15. Nizatidine versus cimetidine in the treatment of duodenal ulcers.
Yap CK; Chong YY; Chia SC; Fock KM
Ann Acad Med Singap; 1991 Mar; 20(2):241-3. PubMed ID: 1679316
[TBL] [Abstract][Full Text] [Related]
16. [German language reprints of original papers from the supplement "Nizatidine in peptic ulcer disease" of the Scandinavian Journal of Gastroenterology, Volume 22, Supplement 136, 1987].
Fortschr Med; 1989 Jan; Spec No 1():1-48. PubMed ID: 2563715
[No Abstract] [Full Text] [Related]
17. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study.
Hentschel E; Schütze K; Reichel W; Kerstan E; Kratochvil P; Brandstätter G; Judmaier G; Keohane PP
Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260
[TBL] [Abstract][Full Text] [Related]
18. Treatment of duodenal ulceration in the United States.
Dyck WP; Cloud ML; Offen WW; Matsumoto C; Chernish SM
Scand J Gastroenterol Suppl; 1987; 136():47-55. PubMed ID: 2892255
[TBL] [Abstract][Full Text] [Related]
19. New histamine H2-receptor antagonists.
Domschke S; Domschke W
Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
[No Abstract] [Full Text] [Related]
20. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
